We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$618M
AUM Growth
+$34.4M
Cap. Flow
-$12M
Cap. Flow %
-1.95%
Top 10 Hldgs %
23.3%
Holding
492
New
15
Increased
–
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$318K
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$259K
3
MAN icon
ManpowerGroup
MAN
+$241K
4
UHS icon
Universal Health Services
UHS
+$236K
5
IR icon
Ingersoll Rand
IR
+$225K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.1M
2
CTXS
Citrix Systems Inc
CTXS
+$2.08M
3
KLAC icon
KLA
KLAC
+$1.36M
4
ORCL icon
Oracle
ORCL
+$912K
5
ITW icon
Illinois Tool Works
ITW
+$745K

Sector Composition

Rank Sector Weight
1 Technology 23.28%
2 Healthcare 15.2%
3 Financials 13.94%
4 Industrials 12.19%
5 Consumer Discretionary 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KLAC icon
26
KLA
KLAC
$239B
$4.19M 0.68%
111,000
-39,000
-26% -$1.36M
RTX icon
27
RTX Corp
RTX
$290B
$4.16M 0.67%
41,215
– –
CVS icon
28
CVS Health
CVS
$133B
$4.08M 0.66%
43,766
– –
KO icon
29
Coca-Cola
KO
$377B
$4.01M 0.65%
63,000
– –
DE icon
30
Deere & Co
DE
$160B
$3.9M 0.63%
9,100
– –
PM icon
31
Philip Morris
PM
$297B
$3.85M 0.62%
38,000
– –
COST icon
32
Costco
COST
$422B
$3.83M 0.62%
8,400
– –
LIN icon
33
Linde
LIN
$221B
$3.75M 0.61%
11,500
-1,500
-12% -$470K
ABBV icon
34
AbbVie
ABBV
$443B
$3.71M 0.6%
22,964
– –
LOW icon
35
Lowe's Companies
LOW
$117B
$3.71M 0.6%
18,600
– –
ABT icon
36
Abbott
ABT
$183B
$3.61M 0.58%
32,854
– –
ATVI
37
DELISTED
Activision Blizzard
ATVI
$3.6M 0.58%
47,000
– –
COP icon
38
ConocoPhillips
COP
$147B
$3.54M 0.57%
30,000
– –
MCHP icon
39
Microchip Technology
MCHP
$40.3B
$3.51M 0.57%
50,000
– –
ALL icon
40
Allstate
ALL
$68B
$3.5M 0.57%
25,810
– –
MSI icon
41
Motorola Solutions
MSI
$72.3B
$3.5M 0.57%
13,571
– –
SNPS icon
42
Synopsys
SNPS
$74.4B
$3.43M 0.56%
10,742
– –
PEP icon
43
PepsiCo
PEP
$190B
$3.41M 0.55%
18,851
– –
DIS icon
44
Walt Disney
DIS
$167B
$3.36M 0.54%
38,700
– –
NEE icon
45
NextEra Energy
NEE
$181B
$3.34M 0.54%
40,000
– –
NOC icon
46
Northrop Grumman
NOC
$77.1B
$3.33M 0.54%
6,100
– –
TMO icon
47
Thermo Fisher Scientific
TMO
$213B
$3.3M 0.53%
6,000
– –
QCOM icon
48
Qualcomm
QCOM
$155B
$3.3M 0.53%
30,000
– –
WFC icon
49
Wells Fargo
WFC
$261B
$3.18M 0.51%
77,000
– –
BMY icon
50
Bristol-Myers Squibb
BMY
$133B
$3.16M 0.51%
43,884
– –
1
2
3 4 5

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q4 2022 Portfolio in Review

As of Q4 2022, NJ State Employees Deferred Compensation Plan held 492 positions worth $618M, up 5.9% from $584M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.9%. NJ State Employees Deferred Compensation Plan opened 15 new positions and exited 9, leaving the 492-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • NJ State Employees Deferred Compensation Plan's largest Q4 2022 buy was Apellis Pharmaceuticals: 6,000 shares worth $310K.
  • NJ State Employees Deferred Compensation Plan's biggest Q4 2022 reduction was KLA, cutting an estimated $1.36M.
  • NJ State Employees Deferred Compensation Plan fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $3.1M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 23% of its $618M portfolio in Q4 2022.
  • NJ State Employees Deferred Compensation Plan opened 15 new positions and closed 9 in Q4 2022.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 5.9% quarter-over-quarter to $618M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2022, filed 26 Jan 2023.